CCP puts patient benefit over patient choice in acute merger

By Ben Clover2011-09-30T16:40:00

The Co-operation and Competition Panel has advised, for the first time, that a merger between two rival providers can go ahead, because the potential benefits outweighed the reduction in patient choice.

You need to be a subscriber to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All HSJ news by sector, topic & region
Breaking News announcements
App for mobile and offline reading
Comment and Daily Insights newsletters
Regional roundup newsletters
10 expert briefings every fortnight (Premium only)
Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)

to HSJ

Already a subscriber? Sign into your account here